ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2422

Sexual Activity and Sexual Functioning Among Women with Systemic Sclerosis Compared to Women From a Population Sample

Brooke Levis1, Andrea Burri2, Marie Hudson3, Murray Baron4 and Brett D. Thombs5, 1Epidemiology, McGill University, Montreal, QC, Canada, 2Twin Research and Genetic Epidemiology, King's College, London, United Kingdom, 3Jewish General Hospital, McGill University, Montreal, QC, Canada, 4Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 5Psychiatry, McGill University, Montreal, QC, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: psychosocial factors, quality of life, scleroderma and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Psychology/Social Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Systemic sclerosis (SSc), or scleroderma, is a chronic, multi-system, connective tissue disorder characterized by thickening and fibrosis of the skin and internal organ involvement. Approximately 80% of patients are women, with highest onset rates between ages 30-60. Common problems include pain, fatigue, pruritus, body image distress, depressive symptoms, and general disability. Reduced sexual activity and impaired sexual functioning are also common among women with SSc and, in addition to age and marital status, are associated with disease severity and symptoms. To date, however, no studies have compared the rates of sexual activity and impairment of women with chronic medical disease to general population data. Thus, the objectives of this study were to 1) determine the rates of sexual activity and sexual impairment, stratified by age and marital status, for a SSc sample and a female population sample, 2) identify the odds of sexual activity and sexual impairment for women with SSc compared to the population sample, controlling for age and marital status, 3) identify the domains of sexual function (desire, arousal, lubrication, orgasm, and pain) most closely related to impairment in SSc compared to the general population, and 4) assess the association between sexual domain scores and sexual satisfaction in SSc versus the general population.

Methods: Female SSc patients from the Canadian Scleroderma Research Group Registry were compared to females from a UK population sample. SSc patients were asked whether they had engaged in sexual activities with a partner in the past 4 weeks. Sexually active patients completed a 9-item version of the Female Sexual Function Index (FSFI) and an item on sexual satisfaction. Women from the UK completed the FSFI as part of a study on female sexual dysfunction. Multivariate logistic regression analyses were used to assess the independent association of sample group with sexual activity and impairment status. Analysis of covariance was used to assess differences in sexual domain scores in both samples, controlling for total FSFI scores. Pearson’s correlations were used to assess the association between sexual domain scores and sexual satisfaction.

Results: Among 730 women with SSc, 296 (41%) were sexually active, 181 (61%) of whom were sexually impaired. Among 1,498 women in the population sample, 956 (64%) were sexually active, 420 (44%) of whom were impaired. Adjusting for age and marital status, women with SSc were significantly less likely to be sexually active (OR=0.34, 95%CI=0.28-0.42) and significantly more likely to be sexually impaired (OR=1.88, 95%CI=1.42-2.49), compared to women from the general population. Adjusting for total FSFI scores, women with SSc had significantly worse lubrication and pain scores than women in the general population. All domains were substantially more highly correlated with satisfaction among women with SSc compared to population sample women.

Conclusion: This study highlights that sexual functioning is a problem for many women living with scleroderma and that it is associated with pain and poor lubrication, two known problems for women with SSc.

 


Disclosure:

B. Levis,
None;

A. Burri,
None;

M. Hudson,
None;

M. Baron,
None;

B. D. Thombs,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sexual-activity-and-sexual-functioning-among-women-with-systemic-sclerosis-compared-to-women-from-a-population-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology